Claritas Rx, a data integration and analytics company focused on specialty biopharmaceutical distribution channels, announced today that it has partnered with Turning Point, an innovative specialty pharmacy network comprised of the largest independent, top-performing specialty pharmacies, to provide biopharmaceutical manufacturers in-depth analytics and insight based on data from the Turning Point specialty pharmacy network.
“Claritas is the perfect partner due to the cultural fit and expertise,” said Erik Halstrom, Managing Director of Turning Point. “The partnership combines Turning Point data with Claritas’ analytics providing manufacturers longitudinal insight into how patients experience treatment milestones across a therapeutic category. Providing manufacturers with faster, more actionable competitive insight and better forecasting, with visibility before and after treatment initiation, is so important as manufacturers look at market dynamics in their therapeutic categories.”
Read the press release here.
Image by: thirdman/©pexels.com